HMH Holding Inc. (HMH) Key Metrics
HMH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $206.3M
- Enterprise value
- $349.1M
- P/E (TTM)
- 25.4
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.3
- Price / book
- 1.1
- EV / EBITDA
- 3.0
- Dividend yield
- —
- Beta
- —
HMH key metrics, 2022–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHMH returns How much profit the business earns on the capital it uses.
HMH per-share figures Results divided by the shares outstanding at year-end.
HMH financial health Debt, liquidity and how easily interest is covered.
HMH efficiency & capital use Working capital cycle and where the cash goes.
HMH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HMH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HMH key metrics
2022–2025| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Per share | ||||
| Revenue per share | $18.68 | $19.17 | $17.85 | $15.39 |
| Earnings per share | $1.03 | $1.16 | $0.40 | −$0.60 |
| Operating cash flow per share | $2.01 | $0.79 | $0.58 | $0.02 |
| Free cash flow per share | $1.62 | $0.37 | $0.02 | −$0.32 |
| Cash per share | $2.20 | $1.11 | $1.42 | $1.08 |
| Book value per share | $15.88 | $14.32 | $13.48 | $12.89 |
| Tangible book value per share | $6.13 | $4.41 | $3.59 | $2.82 |
| Capex per share | $0.39 | $0.42 | $0.56 | $0.34 |
| Debt per share | $8.87 | $7.47 | $7.18 | $6.03 |
| Shares outstanding | 44.0M | 44.0M | 44.0M | 44.0M |
| Change in shares outstanding | 0.0% | 0.0% | 0.0% | — |
| Returns & profitability | ||||
| Return on equity (ROE) | 6.8% | 8.4% | 3.0% | −4.7% |
| Return on invested capital (ROIC) | 7.5% | 9.2% | 5.1% | 2.0% |
| Return on assets (ROA) | 3.3% | 3.7% | 1.3% | −2.1% |
| Return on tangible assets | 4.9% | 5.4% | 1.9% | −3.1% |
| Free cash flow margin | 8.7% | 1.9% | 0.1% | −2.1% |
| Income quality (OCF / net income) | 1.94 | 0.68 | 1.47 | — |
| Financial health | ||||
| Total debt | $390.5M | $328.7M | $316.0M | $265.4M |
| Cash & short-term investments | $96.6M | $48.9M | $62.5M | $47.3M |
| Net debt | $293.9M | $279.8M | $253.5M | $218.0M |
| Debt / equity | 0.56 | 0.52 | 0.53 | 0.47 |
| Debt / assets | 0.29 | 0.24 | 0.23 | 0.21 |
| Net debt / EBITDA | 1.86 | 1.83 | 2.15 | 3.87 |
| Current ratio | 2.81 | 1.94 | 1.67 | 1.43 |
| Quick ratio | 1.68 | 1.12 | 1.03 | 0.93 |
| Interest coverage | 2.6 | 3.2 | 1.7 | 0.6 |
| Working capital | $405.6M | $319.6M | $252.7M | $159.4M |
| Invested capital | $992.5M | $910.0M | $846.7M | $785.3M |
| Tangible asset value | $271.4M | $195.2M | $158.0M | $124.1M |
| Net current asset value | −$28.0M | −$89.9M | −$146.3M | −$194.1M |
| Graham number | $19.21 | $19.37 | $10.95 | — |
| Graham net-net per share | −$5.67 | −$10.72 | −$11.40 | −$11.03 |
| Capital allocation | ||||
| Capex / revenue | 2.1% | 2.2% | 3.1% | 2.2% |
| Capex / operating cash flow | 19.2% | 53.2% | 96.4% | 1,539.1% |
| Capex / depreciation | 0.40 | 0.47 | 0.63 | 0.36 |
| R&D / revenue | 0.3% | 0.8% | 0.4% | 0.4% |
| SG&A / revenue | 18.4% | 17.4% | 16.2% | 20.9% |
| Efficiency | ||||
| Days sales outstanding | 81.1 | 51.8 | 59.5 | 73.4 |
| Days of inventory on hand | 169.1 | 166.8 | 135.3 | 147.5 |
| Days payables outstanding | 52.2 | 70.5 | 66.1 | 76.9 |
| Cash conversion cycle (days) | 198.0 | 148.2 | 128.8 | 143.9 |
| Receivables turnover | 4.50 | 7.05 | 6.13 | 4.97 |
| Payables turnover | 7.00 | 5.18 | 5.52 | 4.74 |
| Inventory turnover | 2.16 | 2.19 | 2.70 | 2.47 |
| Asset turnover | 0.60 | 0.61 | 0.59 | 0.52 |
| Average receivables | $182.6M | $119.7M | $128.1M | $136.2M |
| Average payables | $82.3M | $110.3M | $104.1M | $96.1M |
| Average inventory | $266.9M | $261.1M | $213.2M | $184.2M |
| Intangibles / total assets | 31.6% | 31.6% | 31.8% | 34.2% |
Computed from HMH's annual financial statements (latest annual report filed December 31, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HMH valuation and financial ratios
Based on the latest twelve months, the trailing P/E is 25.4. HMH earned a return on equity of 6.8% and a return on invested capital of 7.5% in fiscal 2025. It ended the year with $390.5 million of debt and $96.6 million in cash and short-term investments, net debt of $293.9 million.
See the HMH income statement, the HMH chart for price history, or the HMH stock overview for the latest quote and news.
HMH key metrics FAQ
What is HMH's P/E ratio?
HMH's trailing P/E ratio is 25.4 based on the last twelve months of earnings (as of October 18, 2026). At the end of fiscal 2025 it was —.
What is HMH's return on equity?
HMH's return on equity (ROE) was 6.8% in fiscal 2025: net income of $45.5 million on average shareholders' equity of $664.4 million.
What is HMH's ROIC?
HMH's return on invested capital was 7.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does HMH have?
HMH had total debt of $390.5 million at the end of fiscal 2025, a debt-to-equity ratio of 0.56 and $293.9 million of net debt (1.86 times EBITDA).
What is HMH's current ratio?
HMH's current ratio was 2.81 at the end of fiscal 2025: current assets were 2.81 times current liabilities.